Quantitative proton MR spectroscopy findings in the corpus callosum of patients with schizophrenia suggest callosal disconnection

American Journal of Neuroradiology

Volumn 28, Issue 10, 2007, Pages 1968-1974

  Aydin, Kubilay ^a,b   Ucok, A ^a   Cakir, S ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; N ACETYLASPARTIC ACID; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MENTAL DISEASE; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; TISSUE WATER;

ADULT; ASPARTIC ACID; CHOLINE; CHRONIC DISEASE; CORPUS CALLOSUM; CREATINE; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 36448938148     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A0691     Document Type: Article

References (56)

1. Wernicke C. Grundrisse der Psychiatric. Leipzig, Germany: Thieme; 1906
2. Stephan KE, Baldeweg T, Friston KJ. Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry 2006;59:929-39. Epub 2006 Jan 19
3. Friston KJ. The disconnection hypothesis. Schizophr Res 1998;30:115-25
4. Crow TJ. Schizophrenia as a transcallosal misconnection syndrome. Schizophr Res 1998;30:111-14
5. Lim KO, Hedehus M, Moseley M, et al. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 1999;56:367-74
6. Park HJ, Westin CF, Kubicki M, et al. White matter hemisphere asymmetries in healthy subjects and in schizophrenia: a diffusion tensor MRI study. Neuroimage 2004;23:213-23
7. Kanaan RA, Kim JS, Kaufmann WE, et al. Diffusion tensor imaging in schizophrenia. Biol Psychiatry 2005;58:921-29. Epub 2005 Jul 25
8. Buchsbaum MS, Friedman J, Buchsbaum BR, et al. Diffusion tensor imaging in schizophrenia. Biol Psychiatry 2006;60:1181-87. Epub 2006 Aug 7
9. Foong J, Maier M, Barker GJ, et al. In vivo investigation of white matter pathology in schizophrenia with magnetization transfer imaging. J Neurol Neurosurg Psychiatry 2000;68:70-74
10. Foong J, Symms MR, Barker GJ, et al. Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. Brain 2001;124:882-92
11. Hakak Y, Walker JR, Li C, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 2001;98:4746-51
12. Iwamoto K, Bundo M, Yamada K, et al. DNA Methylation status of SOX 10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci 2005;25:5376-81
13. Gazzaniga MS. Cerebral specialization and interhemispheric communication: does the corpus callosum enable the human condition. Brain 2000;123:1293-326
14. Crow TJ, Ball J, Bloom SR, et al. Schizophrenia as an anomaly of development of cerebral asymmetry: a postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry 1989;46:1145-50
15. DeLisi LE, Sakuma M, Kushner M, et al. Anomalous cerebral asymmetry and language processing in schizophrenia. Schizophr Bull 1997;23:255-71
16. Downhill JE, Buchsbaum MS, Wei T, et al. Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder. Schizophr Res 2000;42:193-208
17. Keshavan MS, Diwadkar VA, Harenski K, et al. Abnormalities of the corpus callosum in first episode, treatment naive schizophrenia. J Neurol Neurosurg Psychiatry 2002;72:757-60
18. Rosenthal R, Bigelow LB. Quantitative brain measurements in chronic schizophrenia. Br J Psychiatry 1972;121:259-64
19. Nasrallah HA, Andreasen NC, Coffman JA, et al. A controlled magnetic resonance imaging study of corpus callosum thickness in schizophrenia. Biol Psychiatry 1986;21:274-82
20. Casanova MF, Sanders RD, Goldberg TE, et al. Morphometry of the corpus callosum in monozygotic twins discordant for schizophrenia: a magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 1990;53:416-21
21. Woodruff PW, McManus IC, David AS. Meta-analysis of corpus callosum size in schizophrenia. J Neuro Neurosurg Psychiatry 1995;58:457-61
22. Casanova MF, Zito M, Goldberg TE, et al. Corpus callosum curvature in schizophrenic twins. Biol Psychiatry 1990;28:83-84
23. Narr KL, Thompson PM, Sharma T, et al. Mapping morphology of the corpus callosum in schizophrenia. Cereb Cortex 2000;10:40-49
24. Frumin M, Golland P, Kikinis R, et al. Shape differences in the corpus callosum in first-episode schizophrenia and first-episode psychotic affective disorder. Am J Psychiatry 2002;159:866-68
25. Hulshoff Pol HE, Schnack HG, Mandl RC, et al. Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage 2004;21:27-35
26. Diwadkar VA, DeBellis MD, Sweeney JA, et al. Abnormalities in MRI-mea sured signal intensity in the corpus callosum in schizophrenia. Schizophr Res 2004;67:277-82
27. Steel RM, Bastin ME, McConnell S, et al. Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls. Psychiatry Res 2001;106:161-70
28. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I disorders (SCID-I), Clinical Version. Washington, DC; American Psychiatric Press; 1997
29. Pinals D, Malhotra A, Breier A. Informed consent in schizophrenia research. Psychitar Serv 1998;49:244
30. Lukoff D, Nuechterlien K, Ventura A. Manual for the expanded brief psychiatric rating scale. Schizophr Bull 1986;12:594-602
31. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, Iowa; University of Iowa; 1984
32. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, Iowa; University of Iowa; 1983
33. Witelson SF. Hand and sex differences in the isthmus and genu of the human corpus callosum. Brain 1989;112:799-835
34. Highley JR, Esiri MM, McDonald B, et al. The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain 1999;122:99-110
35. Keevil SF, Barbiroli B, Brooks JC, et al. Absolute metabolite quantification by in vivo NMR spectroscopy. II. A multicenter trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging 1998;16:1093-106
36. Michaelis T, Merboldt KD, Bruhn H, et al. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993;187:219-27
37. Hoffman RE, McGlashan TH. Reduced corticocortical connectivity can induce perception pathology and hallucinated voices. Schizophr Res 1998;30:137-41
38. Steen RG, Hamer RM, Lieberman JA. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 2005;30:1949-62
39. Neale JH, Bzdega T, Wroblewska B. N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem 2000;75:443-52
40. Miller BL. A review of chemical issues in H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4:47-52
41. Brandao LA, Domingues RC. MR Spectroscopy of the Brain. Philadelphia: Lippincott, Williams & Wilkins; 2004:17-128
42. Lentz MR, Kim JP, Westmoreland SV, et al. Quantitative neuropathologic correlates of changes in ratio of N-acetylaspartate to creatine in macaque brain. Radiology 2005;235:461-68
43. Najm IM, Wang Y, Shedid D, et al. MRS metabolic markers of seizures and seizure-induced neuronal damage. Epilepsia 1998;39:244-50
44. Aydin K, Ciftci K, Terzibasioglu E, et al. Quantitative proton MR spectroscopic findings of cortical reorganization in the auditory cortex of musicians. AJNR Am J Neuroradiol 2005;26:128-36
45. Nasrallah HA, Mccalley-Whitters M, Bigelow LB, et al. A histological study of the corpus callosum in chronic schizophrenia. Psychiatry Res 1983;8:251-60
46. Casanova MF, Zito M, Bigelow LB, et al. Axonal counts of the corpus callosum of schizophrenic patients. J Neuropsychiatry Clin Neurosci 1989;1:391-93
47. Lieberman JA, Perkins D, Beiger A, et al. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry 2001;50:884-97
48. Uranova NA, Vostrikov VM, Orlovskaya DD, et al. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 2004;67:269-75
49. Uranova N, Orlovskaya D, Vikhreva O, et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull 2001;55:597-610
50. Hof PR, Haroutunian V, Copland C, et al. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res 2002;27:1193-200
51. Peirce TR, Bray NJ, Williams NM, et al. Convergent evidence for 2′,3′-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch Gen Psychiatry 2006;63:18-24
52. Hyde TM, Ziegler JC, Weinberger DR. Psychiatric disturbances in metachromatic leukodystrophy: insights into the neurobiology of psychosis. Arch Neurol 1993;50:401-06
53. MacKay A, Laule C, Vavasour I, et al. Insights into brain microstructure from the T2 distribution. Mag Reson Imaging 2006;24:515-25
54. Flynn SW, Lang DJ, Mackay AL, et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry 2003;8:811-20
55. Bertolino A, Callicott JH, Mattay VS, et al. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry 2001;49:39-46
56. Bustillo J, Wolff C, Myers-y-Gutierrez A, et al. Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels. Schizophr Res 2004;66:31-39